Starling Oncology, Inc. (STLNW) Stock buybacks 2021–2024
Starling Oncology, Inc. (STLNW) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2024 · since FY2021: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | -100.0% |
| FY2023 | $1.0M | -88.7% |
| FY2022 | $9.0M | — |
| FY2021 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice